Despite rumblings about how US health czar Robert F Kennedy Junior will reshape the US Food and Drug Administration (FDA), ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact Report ROCKVILLE, MD, UNITED STATES, March 13, ...

Vishal Manchanda, Pharma Analyst at Systematix Group, stated that Sun Pharmaceutical stands to gain significantly from its recent acquisition of Checkpoint Therapeutics, as it provides access to the ...

Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical ...

The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...

Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...

Shares of Sun Pharmaceutical Industries rose more than 3 per cent following ICICI Securities' upgrade of the stock to a 'Buy' ...